Amarin (AMRN)
(Delayed Data from NSDQ)
$0.88 USD
0.00 (0.24%)
Updated Apr 29, 2024 04:00 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AMRN 0.88 0.00(0.24%)
Will AMRN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AMRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMRN
Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe
Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates
AMRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Rising Operating Costs Affect Acadia's (ACHC) Q4 Earnings?
Can Higher Admissions Drive Universal Health (UHS) Q4 Earnings?
Aquestive (AQST) to Report Q4 Earnings: Here's What to Expect
Other News for AMRN
Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
12 Health Care Stocks Moving In Wednesday's After-Market Session
ArriVent Appoints Kristine Peterson to its Board of Directors
Amarin Shareholders Show Strong Support at Annual Meeting
Amarin Announces Results of Annual General Meeting of Shareholders